<DOC>
	<DOCNO>NCT00006643</DOCNO>
	<brief_summary>The purpose study find Single Photon Emission Computed Tomography ( SPECT ) scan effective liver biopsy ( use special needle remove tissue liver ) examine liver damage patient HIV hepatitis C virus ( HCV ) . A standard way examine liver disease perform liver biopsy . The SPECT scan , take picture liver , find effective determine liver damage study need do patient hepatitis . This study compare effectiveness liver biopsy SPECT scan determine liver disease patient HIV HCV . The SPECT scan might good replacement liver biopsy find good good liver biopsy .</brief_summary>
	<brief_title>Comparing Single Photon Emission Computed Tomography ( SPECT ) Liver Biopsy Evaluate Liver Patients With HIV Hepatitis C Virus</brief_title>
	<detailed_description>Assessment liver biopsy currently standard practice determine status liver involvement patient HCV . A direct comparison SPECT result liver pathology examine patient liver disease infectious hepatitis . SPECT find accurate standard liver-spleen scan assess liver pathology . While current data suggest liver pathology may correlate SPECT , specific SPECT parameter predictive certain hepatic pathology unknown . The pilot study compare SPECT parameter result liver biopsy determine limitation SPECT . All screen patient registered Step 1 , receive radioactive tracer injection SPECT scan . Specific SPECT parameter measure determine grade scale correspond use liver biopsy result . Some patient undergoing second liver biopsy A5071 enrol Step 2 , permission protocol co-chairs , pregnancy test second SPECT scan perform . Patients reimburse complete SPECT scan . SPECT scan copy review establish parameter correspond category E Knodell stage base severity fibrosis .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are enrol , soon enroll , A5071 . Patients may eligible study screen A5071 liver biopsy SPECT scan enter A5071 . Patients stop take A5071 study drug may also eligible . Have liver biopsy , soon liver biopsy . Have SPECT scan either liver biopsy 2 week 8 week liver biopsy . Intend SPECT scan within 7 day study entry . Exclusion Criteria Patients eligible study : Are allergic chemical radioactive tracer use SPECT scan . Are pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2003</verification_date>
	<keyword>Liver</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>Biopsy</keyword>
	<keyword>Tomography , Emission-Computed , Single-Photon</keyword>
</DOC>